Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

SELL
$36.71 - $44.15 $548,006 - $659,071
-14,928 Reduced 65.05%
8,020 $333,000
Q1 2023

Jun 13, 2024

BUY
$36.81 - $48.12 $327,682 - $428,364
8,902 New
8,902 $367,000
Q4 2022

Feb 01, 2023

BUY
$35.68 - $44.71 $480,145 - $601,662
13,457 Added 141.79%
22,948 $946,000
Q3 2022

Nov 10, 2022

SELL
$42.51 - $54.02 $64,572 - $82,056
-1,519 Reduced 13.8%
9,491 $432,000
Q2 2022

Aug 11, 2022

BUY
$46.84 - $59.75 $36,909 - $47,083
788 Added 7.71%
11,010 $561,000
Q1 2022

May 12, 2022

BUY
$48.09 - $57.79 $70,307 - $84,488
1,462 Added 16.69%
10,222 $585,000
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $895,619 - $1.19 Million
-18,979 Reduced 68.42%
8,760 $457,000
Q3 2021

Nov 12, 2021

SELL
$56.91 - $67.81 $1.57 Million - $1.87 Million
-27,559 Reduced 49.84%
27,739 $1.73 Million
Q2 2021

Aug 12, 2021

BUY
$64.02 - $71.72 $3.54 Million - $3.97 Million
55,298 New
55,298 $3.83 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.